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erfusion Abnormality, Normal
oronaries, and Chest Pain*
udley J. Pennell, MD, FRCP, FESC, FACC
ondon, United Kingdom
he subject of patients with recurrent chest pain but normal
oronary arteries provokes controversy. The patients cer-
ainly exist, but their characterization and management is
iscomforting. Such patients are a heterogenous group, and
here are difficulties in confidently sub-phenotyping many
atients beyond their clinical presentation. Perhaps a ma-
ority will have symptoms that are unlikely to be related to
he heart in which the coronary angiogram was performed
rimarily to exclude significant epicardial coronary stenosis.
oronary spasm is well recognized as a cause of chest pain
f cardiac origin but is considered uncommon. Microvas-
ular dysfunction occurs in conditions such as left ventric-
lar hypertrophy of pressure or volume overload, cardiomy-
pathy, and diabetes, and these also might result in chest
ain of likely cardiac origin, because of identifiable alter-
tions in arteriolar structure and stress perfusion. And then
here is cardiac syndrome X (CSX), in which patients mimic
oronary artery disease on exercise testing, but general
greement is lacking over the phenotypic definition and
hether the symptoms have a cardiac origin.
See page 466
The paper by Lanza et al. (1) in this issue of the Journal
mproves our knowledge in CSX by directly comparing
yocardial perfusion and coronary Doppler in the same
atients and in the same territories. With cardiovascular
agnetic resonance (CMR) with the first pass gadolinium
nhancement perfusion technique, they showed that 10 of
8 (56%) patients with CSX (all patients had ST-segment
epression and angina during an exercise test) had stress-
nduced subendocardial perfusion defects on visual analysis,
hich was a significantly greater proportion than in control
ubjects (0 of 10, 0%; p  0.004). In the CSX patients with
nterior wall perfusion abnormality, they also showed re-
Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.
From Imperial College and Royal Brompton Hospital, London, United Kingdom.r
r. Pennell is a consultant to and receives research support from Siemens. He is a
irector of CVIS, which makes image analysis software (both $10,000).uced coronary flow reserve in the left anterior descending
rtery compared with patients without anterior wall abnor-
ality (1.69 vs. 2.31; p  0.01). Finally, they showed a
ignificant relation between the perfusion defect score and
he coronary flow reserve (r  0.45; p  0.019). These
esults strongly indicate that the perfusion abnormality
dentified visually by CMR is a substantive finding and are
n agreement with the controlled study using CMR by
anting et al. (2), who found visual perfusion abnormality
y CMR in 18 of 20 patients with CSX (all patients had
T-segment depression and angina during an exercise test)
ut only 3 of 10 control subjects (90% vs. 30%; p  0.002).
he results also indicate the presence of microvascular
ysfunction and are compatible (but not diagnostic) with
he origin of the cardiac symptoms being from the heart.
hether this is combined with an altered pain threshold or
roblems with other sites of pain perception is not ad-
ressed.
Both of these studies are at variance, however, with the
esults of a recent study by Vermeltfoort et al. (3), in which
he visual findings by perfusion CMR were labeled as
rtifactual. However, closer inspection of this study reveals
hat their patients and study techniques are not comparable
o those of Lanza et al. (1) and Panting et al. (2). Vermeltfoort
t al. (3) studied 20 patients with chest pain and normal
oronary angiography, with 95% having abnormal perfusion
ingle-photon emission computed tomography (SPECT)
ut only 25% having ST-segment depression with exercise.
anting et al. (2) and Lanza et al. (1) studied only patients
ith exercise-induced angina and ST-segment depression.
mportantly the selection of patients’ group by abnormal
erfusion SPECT might yield a very different group from
hat selected by abnormal exercise electrocardiography. This
trikes at the heart of how CSX is defined, an issue on which
here is no universal agreement. Classical diagnosis calls for
n abnormal exercise test (4), but more recently some feel
hat any diagnostic test for ischemia is satisfactory (espe-
ially perfusion SPECT) and that CSX might be best
elabeled as just 1 cause of microvascular dysfunction (5).
here is concern, however, that the criteria for abnormality
ith perfusion SPECT might be less well defined than the
equirement for exercise (0.1 mV horizontal or downsloping
T-segment depression at 80 ms after the J point). Tweddel
t al. (6) reported a 98% prevalence of perfusion SPECT
bnormality in patients with angina and normal coronary
ngiography, but only a 30% prevalence of an abnormal
xercise electrocardiogram (ECG). However, Panting et al.
2) reported that 79% of CSX patients with an abnormal
tress ECG had normal perfusion SPECT. This suggests
hat the population of patients with an abnormal exercise
CG or an abnormal perfusion SPECT is not directly
omparable. The second unexplained anomaly in the article
y Vermeltfoort et al. (3) is the difficulty in their labeling of
ll the CMR perfusion results as “artefacts.” This was
eported in 93% of all the slice series. In 44% of the slice
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Editorial Comment January 29, 2008:473–5eries, it was around the entire subendocardium. This
mplies that nearly all the reported CMR perfusion scans
one are artefactual, which is very much higher than general
xperience. Certainly, global subendocardial artefact by
erfusion CMR in our experience is very uncommon, partly
ecause the spatial resolution of the read-out direction is
sually considerably better than that in the phase encode
irection, which results in any artefacts predominating in
he anteroposterior direction (septum and lateral wall) (7),
ecause this is the phase encode strategy that leads to
reatest scanning efficiency. Because no control group was
ncluded in the study by Vermeltfoort et al. (3), it is unclear
hether the arbitrary assignment of artefact in so many
ases is justified.
The paper by Lanza et al. (1) supports the hypothesis that
he genesis of chest pain in CSX is from the heart. There are
ata to support and oppose this position. The Lanza et al.
1) article accords with the findings of Panting et al. (2),
ho showed subendocardial perfusion abnormality, which is
upportive of a cardiac origin of symptoms. Other evidence
or ischemia from sophisticated investigative techniques in
ecent years has come from magnetic resonance spectros-
opy (8) and coronary sinus sampling of lipoperoxides as a
etabolic marker of ischemia (9). One possible interpreta-
ion of the absence of wall motion abnormalities from stress
tudies in cardiac syndrome X is that if ischemia is indeed
resent, it has characteristics that are not similar to that
ound in coronary artery disease. Conceivably, this might
eflect diffuse abnormality or insufficient transmural exten-
ion. This should not be viewed as solipsistic. We have
uch to learn about the coronary microcirculation and
ndothelial function, and such possibilities need to be
ntertained and tested.
The recent links made between CSX and inflammation
nd endothelial progenitor cells are opportunities for dis-
overy of mechanisms in CSX. The concept of modulation
f chest pain occurrence by inflammation is attractive in
SX, because the clinical condition has clear exacerbations
here presentation with unstable symptoms occurs, which
ight be followed by periods of relative remission. Systemic
nflammation has been shown in CSX, with increased levels
f C-reactive protein (10–12), interleukin-1 receptor antag-
nist (9), and interleukin-6 and tumor necrosis factor
TNF)-alpha (10). The relation of C-reactive protein to
ncreased frequency of chest pain and ST-segment depres-
ion on exercise testing in patients with normal coronary
rteries (13) and the improvement in symptoms, exercise
uration, and endothelial function in CSX with the use of
tatins is consistent with this notion (14–16) and suggests
urther research could bear fruit. The established link
etween CSX and endothelial dysfunction (17) has also
ecently come under new scrutiny. External enhanced
ounter pulsation (EECP) has recently been evaluated (18);
ECP is a novel modulator that improves endothelial
unction (19) and diastolic coronary flow (20). Impressive
esponses in the perfusion CMR scans of individuals have been seen with this treatment (Fig. 1), and improvements in
ymptoms and exercise tolerance have occurred in small
atient groups (R. Roberts, personal communication, Oc-
ober 2007). Finally, in patients with CSX (diagnosed by an
bnormal exercise ECG), Huang et al. (21) found reduced
ndothelial progenitor cells as well as attenuated fibronectin
dhesion function, which might be consistent with an
mpaired endothelium repair capacity. The link to statin
reatment in CSX was made by the demonstration that the
ose dependent suppression of endothelial progenitor cells
y TNF-alpha was reversed by pretreatment with simvasta-
in. This can be interpreted as beneficial, as can the finding
hat statins mobilize endothelial progenitor cells from the
Figure 1 Myocardial Perfusion CMR
(A) Myocardial perfusion cardiovascular magnetic resonance (CMR) in patient
with cardiac syndrome X (CSX). The perfusion CMR scan is from a 68-year-old
woman who presented with a history of disabling angina. The exercise test showed
ST-segment depression, and the coronary arteries were smooth, and therefore
she was diagnosed with “classical” CSX. There is inferior and septal subendo-
cardial perfusion abnormality with adenosine stress (top row, arrows) at basal
and mid levels of the left ventricle, which is not present during the resting per-
fusion study (bottom row). (B) Myocardial perfusion CMR after treatment. The
perfusion CMR scan (identical CMR and stress protocols) on the same patient
9 months later, when the patient had unlimited exercise tolerance. Both stress
and rest scans are now unequivocally normal. The intervention after scan A
was a program of external enhanced counter pulsation therapy.one marrow and improve endothelial function (22,23).
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January 29, 2008:473–5 Editorial Commentesults from a second study were not concordant however
24), possibly owing to a different cell isolation technique
nd diagnostic bias from the inclusion of patients with
bnormal perfusion SPECT.
In conclusion, the study of patients with chest pain but
ormal coronary arteries is in need of rigorous sub-
henotyping. It seems unlikely that this can be achieved by
ixing patients with different forms of abnormal noninva-
ive diagnostic tests, at least until a much clearer picture of
omparisons between tests is established. Perfusion CMR
as the advantage of much higher spatial resolution than
erfusion SPECT, which makes it a good choice for further
valuation; and it would be surprising if perfusion SPECT
ere positive but perfusion CMR were not. Should abnor-
al stress perfusion SPECT be pursued as a diagnostic
riterion for CSX, it would serve the field well to develop a
efinition of abnormality that is suitable for noncoronary
isease (nearly all the published data on perfusion SPECT
re in coronary disease). Agreeing on this definition would
ot be easy, because the border zone between normal and
ossibly abnormal is usually blurred in biological tests (for
hysiological and technical reasons), and low resolution
yocardial perfusion SPECT presents particular challenges
n specificity. It would be helpful to establish the concor-
ance of such phenotyped patients with those with ST-
egment depression and angina on exercise. Should rigorous
ub-phenotyping prove possible, genome-wide association
tudies with achievable sample sizes might be possible with
n international multicenter coordination, which might
rovide new insights into currently unknown mechanisms.
his would greatly clarify diagnosis and present rational
pportunities for new treatments. The one thing that nearly
veryone in the field agrees on is that these patients have
ignificant morbidity from their symptoms with an unre-
uited need for effective treatment.
eprint requests and correspondence: Dr. Dudley J. Pennell,
MR Unit, Royal Brompton Hospital, Sydney Street, London
W3 6NP, United Kingdom. E-mail: d.pennell@ic.ac.uk.
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